Benkwitz Claudia, Liao Mark, Laster Michael J, Sonner James M, Eger Edmond I, Pearce Robert A
Department of Anesthesiology, University of Wisconsin, Madison 53711, USA.
Anesthesiology. 2007 Jan;106(1):114-23. doi: 10.1097/00000542-200701000-00020.
Etomidate is a widely used general anesthetic that has become a useful tool to investigate mechanisms of anesthetic action in vivo and in brain slices. However, the free aqueous concentration of etomidate that corresponds to amnesia in vivo and the diffusion profile of etomidate in brain slices are not known.
The authors assessed the effect of intraperitoneally injected etomidate on contextual fear conditioning in mice. Etomidate concentrations in brain tissue were obtained by high-performance liquid chromatography. Uptake studies in 400-microm-thick brain slices were used to calculate the diffusion and partition coefficients of etomidate. A diffusion model was used to calculate the expected concentration profile within a brain slice as a function of time and depth. The predicted rate of drug equilibration was compared with the onset of electrophysiologic effects on inhibitory circuit function in recordings from hippocampal brain slices.
Etomidate impaired contextual fear conditioning with an ED50 dose of 11.0+/-0.1 mg after intraperitoneal injection, which corresponded to an EC50 brain concentration of 208+/-9 ng/g. The brain:artificial cerebrospinal fluid partition coefficient was 3.35, yielding an EC50,amnesia aqueous concentration of 0.25 microm. The diffusion coefficient was approximately 0.2x10 cm/s. The development of etomidate action in hippocampal brain slices was compatible with the concentration profile predicted by this diffusion coefficient.
The free aqueous concentration of etomidate corresponding to amnesia, as defined by impaired contextual fear conditioning in mice, is 0.25 microM. Diffusion of etomidate into brain slices requires approximately an hour to reach 80% equilibration at a typical recording depth of 100 microm. This information will be useful in designing and interpreting in vitro studies using etomidate.
依托咪酯是一种广泛使用的全身麻醉剂,已成为研究体内和脑片麻醉作用机制的有用工具。然而,体内与遗忘症相对应的依托咪酯游离水浓度以及依托咪酯在脑片中的扩散情况尚不清楚。
作者评估了腹腔注射依托咪酯对小鼠情境性恐惧条件反射的影响。通过高效液相色谱法获得脑组织中的依托咪酯浓度。在400微米厚的脑片中进行摄取研究,以计算依托咪酯的扩散系数和分配系数。使用扩散模型计算脑片内预期的浓度分布随时间和深度的变化。将预测的药物平衡速率与海马脑片记录中对抑制性回路功能的电生理效应的起效时间进行比较。
腹腔注射后,依托咪酯损害情境性恐惧条件反射,半数有效剂量(ED50)为11.0±0.1毫克,这对应于脑内半数有效浓度(EC50)为208±9纳克/克。脑与人工脑脊液的分配系数为3.35,产生与遗忘症相对应的半数有效浓度(EC50)的水浓度为0.25微摩尔。扩散系数约为0.2×10⁻⁵厘米²/秒。依托咪酯在海马脑片中的作用发展与该扩散系数预测的浓度分布相符。
由小鼠情境性恐惧条件反射受损所定义的、与遗忘症相对应的依托咪酯游离水浓度为0.25微摩尔。依托咪酯扩散到脑片中在典型记录深度100微米处达到80%平衡大约需要一小时。这些信息将有助于设计和解释使用依托咪酯的体外研究。